Global Whole Exome Sequencing Market 2023
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
$2,600.00
The global media, sera and reagents market is anticipated to reach valuation of ~USD 7,949 million by 2028, representing a CAGR of 7.2% from 2022 to 2028 as per the latest report by Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global media, sera and reagents market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the media, sera and reagents industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, and region. The global market for media, sera and reagents can be segmented by product: media, reagents, sera. The reagents segment held the largest revenue share in 2021. Media, sera and reagents market is further segmented by region: Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America. Among these, North America was accounted for the highest revenue generator in 2021.
By product:
– media
– reagents
– sera
By region:
– Asia Pacific
– Europe
– North America
– MEA (Middle East and Africa)
– Latin America
The report has also analysed the competitive landscape of the global media, sera and reagents market with some of the key players being Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning Inc, GE Healthcare, Lonza Group AG, Merck KGaA, Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global media, sera and reagents market.
– To classify and forecast the global media, sera and reagents market based on product, region.
– To identify drivers and challenges for the global media, sera and reagents market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global media, sera and reagents market.
– To identify and analyze the profile of leading players operating in the global media, sera and reagents market.
Why Choose This Report
– Gain a reliable outlook of the global media, sera and reagents market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
· Media
· Reagents
· Sera
PART 6. MARKET BREAKDOWN BY REGION
· Asia Pacific
· Europe
· North America
· MEA (Middle East and Africa)
· Latin America
PART 7. KEY COMPANIES
· Becton, Dickinson and Company
· Bio-Rad Laboratories Inc.
· Corning Inc
· GE Healthcare
· Lonza Group AG
· Merck KGaA
· Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Becton, Dickinson and Company
Bio-Rad Laboratories Inc.
Corning Inc
GE Healthcare
Lonza Group AG
Merck KGaA
Thermo Fisher Scientific Inc.
REPORT ATTRIBUTE | DETAILS |
---|---|
Base Year | 2021 |
Forecast Year | 2022-2028 |
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
The global continuous bioprocessing market, in terms of revenue, is expected to grow by 17.9 percent annually through 2029, according to the latest estimates. The top market companies profiles included…
The global virology testing market is projected to expand at a CAGR of ~1.2 percent across the forecast period of 2023 – 2029, according to the latest edition of the…
Please fill out our form and we will get back to you.